Pfizer and Ionis announce discontinuation of vupanorsen clinical development programPRNewsWire • 01/31/22
European Commission Approves LORVIQUA® (lorlatinib) as a First-Line Treatment for ALK-Positive Advanced Lung CancerBusiness Wire • 01/28/22
Pfizer and BioNTech have started testing an Omicron-specific COVID-19 vaccine on adultsBusiness Insider • 01/25/22